Canaan IX L.P., Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 119,242 shares at $10.79 ($1.3M) on 2016-06-02, disclosed to the SEC on 2016-06-06.
Open-market sale of $1.3M CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.79 | 41,193 | $444K | 34.5% |
| 2 | $10.79 | 41,193 | $444K | 34.5% |
| 3 | $10.83 | 18,428 | $200K | 15.5% |
| 4 | $10.83 | 18,428 | $200K | 15.5% |
| Total | $10.80 avg | 119,242 | $1.3M | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-14 | $1.9M | — | Filing → |